WuXi PharmaTech (Cayman) Company Profile (NYSE:WX)

About WuXi PharmaTech (Cayman) (NYSE:WX)

WuXi PharmaTech (Cayman) logoWuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NYSE:WX
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $45.00
  • 200 Day Moving Avg: $43.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 25.93
  • P/E Growth: 0
  • Net Margins: 7.52%
  • Return on Equity: 6.93%
  • Return on Assets: 4.67%

Frequently Asked Questions for WuXi PharmaTech (Cayman) (NYSE:WX)

What is WuXi PharmaTech (Cayman)'s stock symbol?

WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."

How were WuXi PharmaTech (Cayman)'s earnings last quarter?

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) posted its quarterly earnings results on Tuesday, November, 3rd. The company reported $0.31 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.31. The business earned $213.60 million during the quarter, compared to analyst estimates of $205.24 million. WuXi PharmaTech (Cayman) had a return on equity of 6.93% and a net margin of 7.52%. The business's revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.54 earnings per share. View WuXi PharmaTech (Cayman)'s Earnings History.

Who are some of WuXi PharmaTech (Cayman)'s key competitors?

How do I buy WuXi PharmaTech (Cayman) stock?

Shares of WuXi PharmaTech (Cayman) can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is WuXi PharmaTech (Cayman)'s stock price today?

One share of WuXi PharmaTech (Cayman) stock can currently be purchased for approximately $45.90.

MarketBeat Community Rating for WuXi PharmaTech (Cayman) (NYSE WX)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  70 (Vote Underperform)
Total Votes:  187
MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for WuXi PharmaTech (Cayman) (NYSE:WX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for WuXi PharmaTech (Cayman) (NYSE:WX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/5/2015Morgan StanleyDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 9/24/2015 forward)


Earnings History for WuXi PharmaTech (Cayman) (NYSE:WX)
Earnings by Quarter for WuXi PharmaTech (Cayman) (NYSE:WX)
Earnings History by Quarter for WuXi PharmaTech (Cayman) (NYSE WX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2015Q3$0.31$0.31$205.24 million$213.60 millionViewN/AView Earnings Details
8/13/2015Q215$0.39$0.38$195.26 million$194.14 millionViewListenView Earnings Details
5/13/2015Q1$0.32$0.36$174.29 million$180.00 millionViewListenView Earnings Details
3/5/2015Q414$0.53$0.55$189.54 million$190.60 millionViewListenView Earnings Details
11/12/2014Q314$0.48$0.54$172.60 million$173.60 millionViewListenView Earnings Details
8/13/2014Q214$0.47$0.49$162.11 million$163.40 millionViewListenView Earnings Details
5/14/2014Q114$0.39$0.30$145.00 million$146.70 millionViewListenView Earnings Details
3/5/2014Q413$0.43$0.53$155.76 million$157.10 millionViewN/AView Earnings Details
11/13/2013Q313$0.39$0.47$145.29 million$146.70 millionViewListenView Earnings Details
8/12/2013Q2 2013$0.39$0.46$141.10 million$142.33 millionViewN/AView Earnings Details
5/13/2013Q1 2013$0.32$0.35$130.02 million$131.90 millionViewListenView Earnings Details
3/7/2013Q4 2012$0.30$0.38$123.71 million$125.70 millionViewListenView Earnings Details
11/12/2012Q312$0.30$0.36$123.17 million$125.84 millionViewN/AView Earnings Details
8/13/2012$0.30$0.33ViewN/AView Earnings Details
5/10/2012$0.26$0.33ViewN/AView Earnings Details
3/8/2012$0.26$0.31ViewN/AView Earnings Details
11/10/2011$0.27$0.31ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for WuXi PharmaTech (Cayman) (NYSE:WX)
Current Year EPS Consensus Estimate: $1.51 EPS
Next Year EPS Consensus Estimate: $1.77 EPS


Dividend History for WuXi PharmaTech (Cayman) (NYSE:WX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for WuXi PharmaTech (Cayman) (NYSE:WX)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for WuXi PharmaTech (Cayman) (NYSE:WX)
Latest Headlines for WuXi PharmaTech (Cayman) (NYSE:WX)
reuters.com logoUPDATE 2-WuXi Biologics prices HK IPO at top as investors seek growth business
www.reuters.com - June 6 at 2:46 AM
seekingalpha.com logoSky People Fruit Juice (An Update)
seekingalpha.com - January 9 at 3:22 PM
finance.yahoo.com logoWuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors
finance.yahoo.com - September 22 at 7:46 PM
streetinsider.com logoForm N-PX Managed Portfolio Series For: Jun 30
www.streetinsider.com - August 22 at 8:17 PM
bloomberg.com logoChina's Banks Help Finance $157 Billion M&A Spree
www.bloomberg.com - August 9 at 8:40 PM
marketwatch.com logoViral Clearance Market Worth 510.3 Million USD by 2020
www.marketwatch.com - April 4 at 10:45 AM
finance.yahoo.com logoWuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China
finance.yahoo.com - December 16 at 2:40 AM
finance.yahoo.com logoWuXi PharmaTech Presents 2015 Life Science and Chemistry Awards
finance.yahoo.com - December 13 at 6:00 PM
finance.yahoo.com logoWUXI PHARMATECH (CAYMAN) INC. Financials
finance.yahoo.com - December 8 at 1:09 PM
finance.yahoo.com logoDr. Ge Li Receives Executive of the Year Award from SCRIP
finance.yahoo.com - December 7 at 8:00 AM
finance.yahoo.com logoWuXi PharmaTech Announces Shareholders' Approval of Merger Agreement
finance.yahoo.com - November 24 at 10:00 PM
finance.yahoo.com logoThe State Of Chinese Company Take-Private Offers: A Look At WuXi PharmaTech
finance.yahoo.com - November 19 at 7:24 AM
finance.yahoo.com logoISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private Transaction
finance.yahoo.com - November 11 at 12:01 PM
finance.yahoo.com logoWuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China
finance.yahoo.com - November 10 at 4:30 PM



WuXi PharmaTech (Cayman) (WX) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by MarketBeat.com Staff